Supersaturation Potential of Salt, Co-Crystal, and Amorphous Forms of a Model Weak Base

Crystal Growth and Design

Volumn 16, Issue 2, 2016, Pages 737-748

  Almeida E Sousa, Luis ^a   Reutzel Edens, Susan M ^b   Stephenson, Gregory A ^b   Taylor, Lynne S ^a  

^a PURDUE UNIVERSITY   (United States)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMORPHOUS MATERIALS; BIOCHEMISTRY; COBALT; DISPERSIONS; DISSOLUTION; PHASE SEPARATION; POLYMERS; SALTS; SOLUBILITY; SOLUTIONS;

AMORPHOUS SOLID DISPERSIONS; AQUEOUS SOLUBILITY; AREA UNDER THE CURVES; CRYSTALLIZATION INHIBITORS; CRYSTALLIZATION TIME; LIQUID-LIQUID PHASE SEPARATION; SUPERSATURATED AQUEOUS SOLUTIONS; SUPERSATURATED SOLUTIONS;

SUPERSATURATION;

EID: 84957594529     PISSN: 15287483     EISSN: 15287505     Source Type: Journal    
DOI: 10.1021/acs.cgd.5b01341     Document Type: Article

References (42)

1. Fahr, A.; Liu, X. Drug delivery strategies for poorly water-soluble drugs Expert Opin. Drug Delivery 2007, 4 (4) 403-416 10.1517/17425247.4.4.403
2. Poelma, F. G. J.; Breäs, R.; Tukker, J. J.; Crommelin, D. J. A. Intestinal absorption of drugs. The influence of mixed micelles on on the disappearance kinetics of drugs from the small intestine of the rat J. Pharm. Pharmacol. 1991, 43 (5) 317-324 10.1111/j.2042-7158.1991.tb06697.x
3. Pudipeddi, M.; Serajuddin, A. T. M. Trends in solubility of polymorphs J. Pharm. Sci. 2005, 94 (5) 929-939 10.1002/jps.20302
4. Murdande, S.; Pikal, M.; Shanker, R.; Bogner, R. Solubility advantage of amorphous pharmaceuticals: II. Application of quantitative thermodynamic relationships for prediction of solubility enhancement in structurally diverse insoluble pharmaceuticals Pharm. Res. 2010, 27 (12) 2704-2714 10.1007/s11095-010-0269-5
5. Hancock, B.; Parks, M. What is the true solubility advantage for amorphous pharmaceuticals? Pharm. Res. 2000, 17 (4) 397-404 10.1023/A:1007516718048
6. Ilevbare, G. A.; Taylor, L. S. Liquid-liquid phase separation in highly supersaturated aqueous solutions of poorly water-soluble drugs: Implications for solubility enhancing formulations Cryst. Growth Des. 2013, 13 (4) 1497-1509 10.1021/cg301679h
7. Almeida e Sousa, L.; Reutzel-Edens, S. M.; Stephenson, G. A.; Taylor, L. S. Assessment of the amorphous "solubility" of a group of diverse drugs using new experimental and theoretical approaches Mol. Pharmaceutics 2015, 12 (2) 484-495 10.1021/mp500571m
8. Grohganz, H.; Löbmann, K.; Priemel, P.; Tarp Jensen, K.; Graeser, K.; Strachan, C.; Rades, T. Amorphous drugs and dosage forms J. Drug Delivery Sci. Technol. 2013, 23 (4) 403-408 10.1016/S1773-2247(13)50057-8
9. Shamblin, S. L.; Taylor, L. S.; Zografi, G. Mixing behavior of colyophilized binary systems J. Pharm. Sci. 1998, 87 (6) 694-701 10.1021/JS9704801
10. Simonelli, A. P.; Mehta, S. C.; Higuchi, W. I. Dissolution rates of high energy sulfathiazole-povidone coprecipitates II: Characterization of form of drug controlling its dissolution rate via solubility studies J. Pharm. Sci. 1976, 65 (3) 355-361 10.1002/jps.2600650310
11. Craig, D. Q. M. The mechanisms of drug release from solid dispersions in water-soluble polymers Int. J. Pharm. 2002, 231 (2) 131-144 10.1016/S0378-5173(01)00891-2
12. Law, D.; Krill, S. L.; Schmitt, E. A.; Fort, J. J.; Qiu, Y.; Wang, W.; Porter, W. R. Physicochemical considerations in the preparation of amorphous ritonavir-poly(ethylene glycol) 8000 solid dispersions J. Pharm. Sci. 2001, 90 (8) 1015-1025 10.1002/jps.1054
13. Gupta, P.; Kakumanu, V. K.; Bansal, A. K. Stability and solubility of celecoxib-PVP amorphous dispersions: a molecular perspective Pharm. Res. 2004, 21 (10) 1762-9 10.1023/B:PHAM.0000045226.42859.b8
14. Alonzo, D. E.; Gao, Y.; Zhou, D.; Mo, H.; Zhang, G. G. Z.; Taylor, L. S. Dissolution and precipitation behavior of amorphous solid dispersions J. Pharm. Sci. 2011, 100 (8) 3316-3331 10.1002/jps.22579
15. Ilevbare, G. A.; Liu, H.; Pereira, J.; Edgar, K. J.; Taylor, L. S. Influence of additives on the properties of nanodroplets formed in highly supersaturated aqueous solutions of ritonavir Mol. Pharmaceutics 2013, 10 (9) 3392-3403 10.1021/mp400228x
16. Frank, K. J.; Westedt, U.; Rosenblatt, K. M.; Hölig, P.; Rosenberg, J.; Mägerlein, M.; Fricker, G.; Brandl, M. The amorphous solid dispersion of the poorly soluble ABT-102 forms nano/microparticulate structures in aqueous medium: impact on solubility Int. J. Nanomed. 2012, 7, 5757-5768 10.2147/IJN.S36571
17. Aisha, A. F. A.; Ismail, Z.; Abu-salah, K. M.; Majid, A. M. S. A. Solid dispersions of α-mangostin improve its aqueous solubility through self-assembly of nanomicelles J. Pharm. Sci. 2012, 101 (2) 815-825 10.1002/jps.22806
18. Mosquera-Giraldo, L. I.; Taylor, L. S. Glass-liquid phase separation in highly supersaturated aqueous solutions of telaprevir Mol. Pharmaceutics 2015, 12 (2) 496-503 10.1021/mp500573z
19. Good, D. J.; Rodríguez-Hornedo, N. Solubility advantage of pharmaceutical cocrystals Cryst. Growth Des. 2009, 9 (5) 2252-2264 10.1021/cg801039j
20. Good, D. J.; Rodríguez-Hornedo, N. Cocrystal eutectic constants and prediction of solubility Behavior Cryst. Growth Des. 2010, 10 (3) 1028-1032 10.1021/cg901232h
21. Babu, N. J.; Nangia, A. Solubility advantage of amorphous drugs and pharmaceutical cocrystals Cryst. Growth Des. 2011, 11 (7) 2662-2679 10.1021/cg200492w
22. Childs, S. L.; Chyall, L. J.; Dunlap, J. T.; Smolenskaya, V. N.; Stahly, B. C.; Stahly, G. P. Crystal engineering approach to forming cocrystals of amine hydrochlorides with organic acids. Molecular complexes of fluoxetine hydrochloride with benzoic, succinic, and fumaric acids J. Am. Chem. Soc. 2004, 126 (41) 13335-13342 10.1021/ja048114o
23. Chadha, R.; Saini, A.; Arora, P.; Jain, D. S.; Dasgupta, A.; Guru Row, T. N. Multicomponent solids of lamotrigine with some selected coformers and their characterization by thermoanalytical, spectroscopic and X-ray diffraction methods CrystEngComm 2011, 13 (20) 6271-6284 10.1039/c1ce05458a
24. Stanton, M. K.; Kelly, R. C.; Colletti, A.; Kiang, Y. H.; Langley, M.; Munson, E. J.; Peterson, M. L.; Roberts, J.; Wells, M. Improved pharmacokinetics of AMG 517 through co-crystallization part 1: Comparison of two acids with corresponding amide co-crystals J. Pharm. Sci. 2010, 99 (9) 3769-3778 10.1002/jps.22181
25. Childs, S. L.; Kandi, P.; Lingireddy, S. R. Formulation of a danazol cocrystal with controlled supersaturation plays an essential role in improving bioavailability Mol. Pharmaceutics 2013, 10 (8) 3112-3127 10.1021/mp400176y
26. Serajuddin, A. T. M.; Jarowski, C. I. Effect of diffusion layer pH and solubility on the dissolution rate of pharmaceutical acids and their sodium salts II: Salicylic acid, theophylline, and benzoic acid J. Pharm. Sci. 1985, 74 (2) 148-154 10.1002/jps.2600740209
27. Li, S.; Wong, S.; Sethia, S.; Almoazen, H.; Joshi, Y. M.; Serajuddin, A. T. M. Investigation of solubility and dissolution of a free base and two different salt forms as a function of pH Pharm. Res. 2005, 22 (4) 628-635 10.1007/s11095-005-2504-z
28. Ledwidge, M. T.; Corrigan, O. I. Effects of surface active characteristics and solid state forms on the pH solubility profiles of drug-salt systems Int. J. Pharm. 1998, 174 (1-2) 187-200 10.1016/S0378-5173(98)00257-9
29. Guzmán, H. R.; Tawa, M.; Zhang, Z.; Ratanabanangkoon, P.; Shaw, P.; Gardner, C. R.; Chen, H.; Moreau, J.-P.; Almarsson, Ö.; Remenar, J. F. Combined use of crystalline salt forms and precipitation inhibitors to improve oral absorption of celecoxib from solid oral formulations J. Pharm. Sci. 2007, 96 (10) 2686-2702 10.1002/jps.20906
30. Terebetski, J. L.; Michniak-Kohn, B. Combining ibuprofen sodium with cellulosic polymers: A deep dive into mechanisms of prolonged supersaturation Int. J. Pharm. 2014, 475 (1-2) 536-546 10.1016/j.ijpharm.2014.09.015
31. Hsieh, Y.-L.; Ilevbare, G.; Van Eerdenbrugh, B.; Box, K.; Sanchez-Felix, M.; Taylor, L. S. pH-Induced precipitation behavior of weakly basic compounds: Determination of extent and duration of supersaturation using potentiometric titration and correlation to solid state properties Pharm. Res. 2012, 29 (10) 2738-2753 10.1007/s11095-012-0759-8
32. Kalyanasundaram, K.; Thomas, J. K. Environmental effects on vibronic band intensities in pyrene monomer fluorescence and their application in studies of micellar systems J. Am. Chem. Soc. 1977, 99 (7) 2039-2044 10.1021/ja00449a004
33. Murdande, S. B.; Pikal, M. J.; Shanker, R. M.; Bogner, R. H. Solubility advantage of amorphous pharmaceuticals: I. A thermodynamic analysis J. Pharm. Sci. 2010, 99 (3) 1254-1264 10.1002/jps.21903
34. Hoffman, J. D. Thermodynamic driving force in nucleation and growth processes J. Chem. Phys. 1958, 29 (5) 1192-1193 10.1063/1.1744688
35. Van Eerdenbrugh, B.; Alonzo, D.; Taylor, L. S. Influence of particle size on the ultraviolet spectrum of particulate-containing solutions: Implications for in-situ concentration monitoring using UV/Vis fiber-optic probes Pharm. Res. 2011, 28 (7) 1643-1652 10.1007/s11095-011-0399-4
36. Konno, H.; Handa, T.; Alonzo, D. E.; Taylor, L. S. Effect of polymer type on the dissolution profile of amorphous solid dispersions containing felodipine Eur. J. Pharm. Biopharm. 2008, 70 (2) 493-499 10.1016/j.ejpb.2008.05.023
37. Murdande, S. B.; Pikal, M. J.; Shanker, R. M.; Bogner, R. H. Aqueous solubility of crystalline and amorphous drugs: Challenges in measurement Pharm. Dev. Technol. 2011, 16 (3) 187-200 10.3109/10837451003774377
38. Indulkar, A. S.; Box, K. J.; Taylor, R.; Ruiz, R.; Taylor, L. S. pH-dependent liquid-liquid phase separation of highly supersaturated solutions of weakly basic drugs Mol. Pharmaceutics 2015, 12 (7) 2365-2377 10.1021/acs.molpharmaceut.5b00056
39. Alonzo, D.; Zhang, G. Z.; Zhou, D.; Gao, Y.; Taylor, L. S. Understanding the behavior of amorphous pharmaceutical systems during dissolution Pharm. Res. 2010, 27 (4) 608-618 10.1007/s11095-009-0021-1
40. Sun, D. D.; Lee, P. I. Evolution of supersaturation of amorphous pharmaceuticals: The effect of rate of supersaturation generation Mol. Pharmaceutics 2013, 10 (11) 4330-4346 10.1021/mp400439q
41. Shiraki, K.; Takata, N.; Takano, R.; Hayashi, Y.; Terada, K. Dissolution improvement and the mechanism of the improvement from cocrystallization of poorly water-soluble compounds Pharm. Res. 2008, 25 (11) 2581-2592 10.1007/s11095-008-9676-2
42. Merritt, J.; Viswanath, S.; Stephenson, G. Implementing quality by design in pharmaceutical salt selection: A modeling approach to understanding disproportionation Pharm. Res. 2013, 30 (1) 203-217 10.1007/s11095-012-0863-9